FAG
IDXX icon

Fortitude Advisory Group’s Idexx Laboratories IDXX Stock Holding History

Fortitude Advisory Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-134
Closed -$73K – 690
2022
Q1 		$73K Buy
134
+42
+46% +$22.1K 0.04% 420
2021
Q4 		$61K Buy
+92
New +$57.8K 0.03% 483

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Fortitude Advisory Group's IDXX Position: Q2 2022 in Review

Fortitude Advisory Group sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 134 shares — an estimated $73K sold.

Fortitude Advisory Group first reported a position in IDXX in Q4 2021 and held it in 2 quarters. The position peaked at $73K in Q1 2022. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

  • Fortitude Advisory Group reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
  • Fortitude Advisory Group sold 134 Idexx Laboratories shares in Q2 2022, an estimated $73K.
  • Fortitude Advisory Group first reported a position in Idexx Laboratories in Q4 2021 and held it in 2 quarters.
  • Fortitude Advisory Group's Idexx Laboratories position peaked at $73K in Q1 2022.
  • 956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Fortitude Advisory Group's 13F filing for Q2 2022, filed 16 Aug 2022.